Ratio Review: Analyzing Abbvie Inc (ABBV)’s Price-to-Cash and Price-to-Free Cash Flow

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $199.50 in the prior trading day, Abbvie Inc (NYSE: ABBV) closed at $174.43, down -12.57%. In other words, the price has decreased by -$12.57 from its previous closing price. On the day, 20.66 million shares were traded. ABBV stock price reached its highest trading level at $178.57 during the session, while it also had its lowest trading level at $172.7001.

Ratios:

Our goal is to gain a better understanding of ABBV by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 42.10 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.68. For the most recent quarter (mrq), Quick Ratio is recorded 0.54 and its Current Ratio is at 0.65. In the meantime, Its Debt-to-Equity ratio is 11.78 whereas as Long-Term Debt/Eq ratio is at 9.70.

On October 17, 2024, Bernstein started tracking the stock assigning a Mkt Perform rating and target price of $203.

HSBC Securities Upgraded its Hold to Buy on June 05, 2024, while the target price for the stock was maintained at $185.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 08 ’24 when Hudson Thomas J bought 49,170 shares for $189.08 per share.

GONZALEZ RICHARD A sold 66,500 shares of ABBV for $12,403,580 on Aug 05 ’24. The EXECUTIVE CHAIRMAN OF BOARD now owns 446,599 shares after completing the transaction at $186.52 per share. On Aug 07 ’24, another insider, Hudson Thomas J, who serves as the Officer of the company, bought 101,886 shares for $187.62 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABBV now has a Market Capitalization of 308242219008 and an Enterprise Value of 372319289344. As of this moment, Abbvie’s Price-to-Earnings (P/E) ratio for their current fiscal year is 60.83, and their Forward P/E ratio for the next fiscal year is 14.39. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 7.32. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.52 while its Price-to-Book (P/B) ratio in mrq is 51.10. Its current Enterprise Value per Revenue stands at 6.704 whereas that against EBITDA is 14.527.

Stock Price History:

Over the past 52 weeks, ABBV has reached a high of $207.32, while it has fallen to a 52-week low of $135.85. The 50-Day Moving Average of the stock is -10.15%, while the 200-Day Moving Average is calculated to be -2.48%.

Shares Statistics:

The stock has traded on average 4.68M shares per day over the past 3-months and 6018580 shares per day over the last 10 days, according to various share statistics. A total of 1.77B shares are outstanding, with a floating share count of 1.77B. Insiders hold about 0.09% of the company’s shares, while institutions hold 72.98% stake in the company. Shares short for ABBV as of 1728950400 were 16183592 with a Short Ratio of 3.46, compared to 1726185600 on 17793512. Therefore, it implies a Short% of Shares Outstanding of 16183592 and a Short% of Float of 0.9199999999999999.

Dividends & Splits

In the trailing 12 months, ABBV’s forward annual dividend rate was 6.2, compared to 6.20 this year. Against a Trailing Annual Dividend Yield of 0.031077694The stock’s 5-year Average Dividend Yield is 4.16.

Most Popular